Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)’s share price was down 3.7% during mid-day trading on Wednesday . The stock traded as low as $2.78 and last traded at $2.83, with a volume of 1,027,696 shares. The stock had previously closed at $2.94.

Separately, Maxim Group reissued a “buy” rating on shares of Adamis Pharmaceuticals Corp. in a report on Tuesday, May 10th.

The firm has a 50-day moving average price of $2.86 and a 200-day moving average price of $5.25. The company’s market capitalization is $57.85 million.

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.